Metronomic PLD in Patients With Primary Endocrine Resistant ABC
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Pegylated Liposomal Doxorubicin
Sponsor: Fudan University